Navigating the kinome.

Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biology and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacology-dependent networks. Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacology parameters derived from activity profiling data. The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is critical for multitargeted drug design.

[1]  J W Godden,et al.  Shannon entropy--a novel concept in molecular descriptor and diversity analysis. , 2000, Journal of molecular graphics & modelling.

[2]  Jürgen Bajorath,et al.  An Information-Theoretic Approach to Descriptor Selection for Database Profiling and QSAR Modeling , 2003 .

[3]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[4]  M. Vieth,et al.  Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. , 2004, Biochimica et biophysica acta.

[5]  M. Vieth,et al.  Kinomics: characterizing the therapeutically validated kinase space. , 2005, Drug discovery today.

[6]  S. Frantz.  Drug discovery: Playing dirty , 2005, Nature.

[7]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[8]  Tudor I. Oprea,et al.  Systems chemical biology. , 2007 .

[9]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[10]  Gavin Harper,et al.  Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. , 2008, Journal of medicinal chemistry.

[11]  R. Solé,et al.  Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.

[12]  R. Solé,et al.  The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.

[13]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[14]  P. Hajduk,et al.  Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks. , 2010, Current opinion in chemical biology.

[15]  J. Mestres,et al.  Drug‐Target Networks , 2010, Molecular informatics.

[16]  R. Morphy.  Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.